01 July 1997
Natural therapy of children with chronic persistent hepatitis B. Preliminary report
Dorota Sienkiewicz, Maciej Kaczmarski, Dariusz Marek LebensztejnMed Sci Monit 1997; 3(4): SR446-450 :: ID: 501492
Abstract
The subject of the study was a group of 10 children, aged 3-11 (2 girls, 8 boys), patients of the 3rd Department of Children Diseases of Medical Academy in Bia3ystok, who were diagnosed with chronic hepatitis type B. The etiology of this disease is infection with HB virus with the following immunologic profile: HBsAg(+), HBeAg(+), anti-HBs(-), anti-HBe(-). The ALAT activity (mean value - 55.0IU) and mean polymerase HBV DNA (4121.8cpm) activity were assessed prior to treatment; the patients showed cellular immunity disturbances. Natural anthroposophical drugs were administered in 4-week cycles as subcutaneous injections: Taraxacum Stanno cultum 0.1% (4 cycles), Hepar/Stannum D15/20 (8 cycles); and Hepatodoron as pills in daily doses. The patients were re-evaluated clinically every 3 months and ALAT and polymerase HBV DNA activity as well as cellular immunity and HBV markers were monitored every 6 months. After 12 months of therapy the following results were obtained: polymerase HBV DNA activity decreased in all of the patients to the mean value of 785.0cpm, sero-conversion in HBeAg/anti-Hbe markers occurred in 12.5% of the children and a tendency to normalization of the cellular immunity measured by rosette test occurred in 87.5% of the patients. These observations show that chronic hepatitis B is accompanied by the disorders of cellular immunity and that that natural drugs can influence the improvement of cellular immunity in patients with this type of hepatitis; they also seem to halt HBV replication which leads to full elimination of the virus from infected liver cells.
Keywords: chronic persistent hepatitis B, children, natural anthroposophical drugs, polymerase HBV DNA, cellular immunity
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952